Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2023 Filed Aug 7, 2023 17:07 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantRestricted Stock Units · Derivative | 39.0844 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022088 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 603.2033 Underlying: Common Stock · 39.0844 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 15, 2023 Filed Aug 7, 2023 17:08 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantRestricted Stock Units · Derivative | 184.1669 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022089 · form4.xml · derivative · entry 8 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,913.3984 Underlying: Common Stock · 184.1669 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 15, 2023 Filed Aug 7, 2023 17:12 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantRestricted Stock Units · Derivative | 10.5114 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022091 · form4.xml · derivative · entry 4 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58.7042 Underlying: Common Stock · 10.5114 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 15, 2023 Filed Aug 7, 2023 17:13 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 0.5689 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022092 · form4.xml · derivative · entry 3 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.837 Underlying: Common Stock · 0.5689 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 15, 2023 Filed Aug 7, 2023 17:16 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 22.0867 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022093 · form4.xml · derivative · entry 6 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305.154 Underlying: Common Stock · 22.0867 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 01, 2023 Filed May 2, 2023 12:58 UTC |
Jejurikar ShaileshChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-23-013996 · form4.xml · derivative · entry 8 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,275 Underlying: Common Stock · 31,000 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2023 Filed May 2, 2023 12:58 UTC |
Jejurikar ShaileshChief Operating Officer
|
SaleCommon Stock | 31,000 | $156.03 | $4,836,930.00 |
DisclosureSEC source: 0001127602-23-013996 · form4.xml · nonDerivative · entry 2 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,013.6053 Read SEC document |
| May 01, 2023 Filed May 2, 2023 12:58 UTC |
Jejurikar ShaileshChief Operating Officer
|
Exercise / conversionCommon Stock | 31,000 | $80.29 | $2,488,990.00 |
DisclosureSEC source: 0001127602-23-013996 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,013.6053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| April 26, 2023 Filed Apr 27, 2023 17:01 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,269 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-23-013632 · form4.xml · derivative · entry 8 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,269 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2023 Filed Apr 27, 2023 17:01 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,153 | $0.00 Strike: $78.66 | $0.00 |
DisclosureSEC source: 0001127602-23-013632 · form4.xml · derivative · entry 7 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,153 shares Expires 2024-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2023 Filed Apr 27, 2023 17:01 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
SaleCommon Stock | 7,269 | $155.77 | $1,132,272.50 |
DisclosureSEC source: 0001127602-23-013632 · form4.xml · nonDerivative · entry 5 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 882.5679 F1 · price: Weighted average price of the shares sold. The price range was $155.73 to $155.86. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| April 26, 2023 Filed Apr 27, 2023 17:01 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
Exercise / conversionCommon Stock | 7,269 | $85.13 | $618,809.97 |
DisclosureSEC source: 0001127602-23-013632 · form4.xml · nonDerivative · entry 4 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,151.5679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2023 Filed Apr 27, 2023 17:01 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
SaleCommon Stock | 6,153 | $155.77 | $958,436.20 |
DisclosureSEC source: 0001127602-23-013632 · form4.xml · nonDerivative · entry 3 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 882.5679 F1 · price: Weighted average price of the shares sold. The price range was $155.73 to $155.86. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| April 26, 2023 Filed Apr 27, 2023 17:01 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
Exercise / conversionCommon Stock | 6,153 | $78.66 | $483,994.98 |
DisclosureSEC source: 0001127602-23-013632 · form4.xml · nonDerivative · entry 2 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,035.5679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2023 Filed Apr 27, 2023 17:01 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
SaleCommon Stock | 275 | $155.50 | $42,763.46 |
DisclosureSEC source: 0001127602-23-013632 · form4.xml · nonDerivative · entry 1 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 882.5679 Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 16:11 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,631 | $0.00 Strike: $113.23 | $0.00 |
DisclosureSEC source: 0001127602-23-013740 · form4.xml · derivative · entry 5 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,632 Underlying: Common Stock · 2,631 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 16:11 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 2,221 | $155.47 | $345,298.87 |
DisclosureSEC source: 0001127602-23-013740 · form4.xml · nonDerivative · entry 3 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,976.6584 Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 16:11 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 2,631 | $155.47 | $409,041.57 |
DisclosureSEC source: 0001127602-23-013740 · form4.xml · nonDerivative · entry 2 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,197.6584 Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 16:11 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
Exercise / conversionCommon Stock | 2,631 | $113.23 | $297,908.13 |
DisclosureSEC source: 0001127602-23-013740 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,828.6584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 18:41 UTC |
Coombe Gary ACEO - Grooming
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,337 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-23-013561 · form4.xml · derivative · entry 7 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,337 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 18:41 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 14,337 | $157.00 | $2,250,909.00 |
DisclosureSEC source: 0001127602-23-013561 · form4.xml · nonDerivative · entry 2 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,798.7238 Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 18:41 UTC |
Coombe Gary ACEO - Grooming
|
Exercise / conversionCommon Stock | 14,337 | $85.13 | $1,220,508.81 |
DisclosureSEC source: 0001127602-23-013561 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,135.7238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| April 24, 2023 Filed Apr 24, 2023 19:06 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 8,000 | $156.84 | $1,254,720.00 |
DisclosureSEC source: 0001127602-23-013436 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,343.1022 F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 16:22 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 6,762 | $156.12 | $1,055,691.55 |
DisclosureSEC source: 0001127602-23-013502 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,387.9361 F1 · price: Weighted average price of the shares sold. The price range was $156.12 to $156.145. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 16:22 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,507 | $155.27 | $233,991.89 |
DisclosureSEC source: 0001127602-23-013502 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 6,046.0229 Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:08 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,300 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-23-013503 · form4.xml · derivative · entry 4 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,629 Underlying: Common Stock · 12,300 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:08 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 12,300 | $156.33 | $1,922,868.84 |
DisclosureSEC source: 0001127602-23-013503 · form4.xml · nonDerivative · entry 2 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,001.4185 F1 · price: Weighted average price of the shares sold. The price range was $156.32 to $156.36. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:08 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionCommon Stock | 12,300 | $85.13 | $1,047,099.00 |
DisclosureSEC source: 0001127602-23-013503 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,301.4185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:10 UTC |
Schulten AndreChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,220 | $0.00 Strike: $78.66 | $0.00 |
DisclosureSEC source: 0001127602-23-013504 · form4.xml · derivative · entry 5 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,220 shares Expires 2024-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:10 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 17,220 | $155.27 | $2,673,749.40 |
DisclosureSEC source: 0001127602-23-013504 · form4.xml · nonDerivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,117.9997 Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:10 UTC |
Schulten AndreChief Financial Officer
|
Exercise / conversionCommon Stock | 17,220 | $78.66 | $1,354,525.20 |
DisclosureSEC source: 0001127602-23-013504 · form4.xml · nonDerivative · entry 2 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,337.9997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:10 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 8,024 | $155.27 | $1,245,886.48 |
DisclosureSEC source: 0001127602-23-013504 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,117.9997 Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:21 UTC |
Davis Jennifer L.CEO - Health Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 23,943 | $0.00 Strike: $78.52 | $0.00 |
DisclosureSEC source: 0001127602-23-013505 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,943 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:21 UTC |
Davis Jennifer L.CEO - Health Care
|
SaleCommon Stock | 23,943 | $155.27 | $3,717,629.61 |
DisclosureSEC source: 0001127602-23-013505 · form4.xml · nonDerivative · entry 2 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,860.3494 Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:21 UTC |
Davis Jennifer L.CEO - Health Care
|
Exercise / conversionCommon Stock | 23,943 | $78.52 | $1,880,004.36 |
DisclosureSEC source: 0001127602-23-013505 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,803.3494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 14:33 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 179 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-010233 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,872.9517 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 14:34 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 215 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-010234 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,700.7476 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 14:35 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 287 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-010235 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,275.0089 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 14:36 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 179 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-010236 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,095.2151 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 14:38 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-010237 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,996.7747 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 14:39 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 179 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-010238 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,268.3674 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 14:40 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 233 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-010239 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,840.63 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 17:27 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,194 | $137.34 | $163,986.23 |
DisclosureSEC source: 0001127602-23-008170 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 7,553.0229 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 17:27 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 5,349 | $137.34 | $734,641.82 |
DisclosureSEC source: 0001127602-23-008170 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,149.9361 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 17:29 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 164 | $137.34 | $22,524.07 |
DisclosureSEC source: 0001127602-23-008171 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 35,221.5707 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 17:29 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 2,151 | $137.34 | $295,422.43 |
DisclosureSEC source: 0001127602-23-008171 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,747.9051 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 17:31 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 695 | $137.34 | $95,452.62 |
DisclosureSEC source: 0001127602-23-008173 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,001.4185 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 17:32 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 1,311 | $137.34 | $180,055.23 |
DisclosureSEC source: 0001127602-23-008174 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,141.9997 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 17:35 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 709 | $137.34 | $97,375.41 |
DisclosureSEC source: 0001127602-23-008175 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,197.6584 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 17:36 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
SaleCommon Stock | 160 | $137.34 | $21,974.70 |
DisclosureSEC source: 0001127602-23-008176 · form4.xml · nonDerivative · entry 1 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157.5679 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.